Oct 31 (Reuters) - Intrinsic Medicine Inc INRX.O :
* INTRINSIC MEDICINE AND PHOENIX BIOTECH ACQUISITION CORP.
ANNOUNCE MERGER AGREEMENT TO CREATE PUBLIC COMPANY LEVERAGING
HUMAN MILK BIOLOGY TO TREAT GUT-BRAIN AXIS DISORDERS
* PHOENIX BIOTECH ACQUISITION CORP - TRANSACTION REFLECTS A
PRE-MONEY EQUITY VALUE OF $136 MILLION FOR INTRINSIC MEDICINE
* PHOENIX BIOTECH ACQUISITION CORP - TRANSACTION EXPECTED
TO
PROVIDE UP TO $178.8 MILLION HELD IN TRUST
* PHOENIX BIOTECH ACQUISITION CORP - COMBINED COMPANY TO BE
LISTED
ON NASDAQ UNDER TICKER "INRX"
Source text for Eikon: ID:nGNX94H6Bf
Further company coverage: INRX.O
((Reuters.Briefs@thomsonreuters.com;))